Theratechnologies Stock Analysis

Theratechnologies Stock Analysis Notes

About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.8. Theratechnologies last dividend was issued on the 18th of October 2000. The entity had 1:4 split on the 31st of July 2023. Theratechnologies Inc., a biopharmaceutical company, markets prescription products in the United States, Europe, and Canada. The company was founded in 1993 and is headquartered in Montreal, Canada. THERATECHNOLOGIES operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 42 people. To find out more about Theratechnologies contact Paul Lvesque at 514 336 7800 or learn more at https://www.theratech.com.

Theratechnologies Investment Alerts

Theratechnologies Largest EPS Surprises

View All Earnings Estimates

Theratechnologies Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 78.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theratechnologies's market, we take the total number of its shares issued and multiply it by Theratechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Theratechnologies Profitablity

The company has Profit Margin (PM) of (0.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

Management Efficiency

Theratechnologies has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (11.1686) %, meaning that it generated substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of June 2024, Return On Equity is likely to grow to 1.39, while Return On Tangible Assets are likely to drop (0.44). At this time, Theratechnologies' Non Current Assets Total are very stable compared to the past year. As of the 2nd of June 2024, Other Current Assets is likely to grow to about 10 M, while Total Assets are likely to drop about 65.2 M.

Technical Drivers

As of the 2nd of June, Theratechnologies has the Risk Adjusted Performance of (0.02), coefficient of variation of (2,242), and Variance of 11.46. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Theratechnologies, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Theratechnologies, which can be compared to its competition. Please validate Theratechnologies coefficient of variation and maximum drawdown to decide if Theratechnologies is priced more or less accurately, providing market reflects its prevalent price of 1.71 per share.

Theratechnologies Price Movement Analysis

Theratechnologies Predictive Daily Indicators

Theratechnologies Forecast Models

Theratechnologies' time-series forecasting models are one of many Theratechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theratechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Theratechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theratechnologies shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Theratechnologies. By using and applying Theratechnologies Stock analysis, traders can create a robust methodology for identifying Theratechnologies entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.